Your browser is no longer supported. Please, upgrade your browser.
Settings
ABCL [NASD]
AbCellera Biologics Inc.
Index- P/E120.71 EPS (ttm)0.24 Insider Own23.30% Shs Outstand590.55M Perf Week9.16%
Market Cap7.78B Forward P/E103.16 EPS next Y0.28 Insider Trans0.00% Shs Float178.40M Perf Month-4.90%
Income118.90M PEG- EPS next Q0.38 Inst Own36.40% Short Float3.31% Perf Quarter-37.51%
Sales218.20M P/S35.63 EPS this Y415.00% Inst Trans1.31% Short Ratio5.35 Perf Half Y-
Book/sh1.41 P/B20.63 EPS next Y-72.30% ROA- Target Price- Perf Year-
Cash/sh2.22 P/C13.09 EPS next 5Y- ROE- 52W Range23.20 - 71.91 Perf YTD-27.71%
Dividend- P/FCF598.11 EPS past 5Y- ROI13.60% 52W High-59.55% Beta-
Dividend %- Quick Ratio7.80 Sales past 5Y- Gross Margin- 52W Low25.39% ATR2.57
Employees206 Current Ratio7.90 Sales Q/Q6391.30% Oper. Margin71.50% RSI (14)48.91 Volatility7.18% 7.28%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin54.50% Rel Volume0.44 Prev Close28.70
ShortableYes LT Debt/Eq0.00 EarningsMar 29 AMC Payout0.00% Avg Volume1.10M Price29.09
Recom1.60 SMA201.14% SMA50-5.12% SMA200-23.35% Volume484,342 Change1.36%
Jan-05-21Initiated SVB Leerink Outperform $45
Jan-05-21Initiated Stifel Buy $59
Jan-05-21Initiated Credit Suisse Outperform $52
Jan-05-21Initiated BMO Capital Markets Outperform $48
Jan-05-21Initiated Berenberg Buy $53
May-06-21 09:00AM  
May-04-21 09:31AM  
06:30AM  
Apr-29-21 04:10PM  
Apr-21-21 04:05PM  
Apr-20-21 11:37AM  
Apr-15-21 07:49AM  
Apr-14-21 04:05PM  
Apr-12-21 04:05PM  
Apr-05-21 02:00PM  
Apr-01-21 09:00AM  
05:38AM  
Mar-29-21 04:05PM  
Mar-25-21 11:51AM  
Mar-16-21 12:51PM  
Mar-13-21 01:00AM  
Mar-10-21 11:21AM  
Mar-05-21 03:30PM  
Feb-27-21 09:23AM  
Feb-17-21 04:05PM  
Feb-11-21 04:05PM  
Feb-10-21 04:15PM  
Feb-09-21 08:26PM  
Feb-03-21 04:05PM  
Jan-28-21 01:08PM  
Jan-27-21 07:22AM  
Jan-26-21 07:09AM  
Jan-21-21 08:27AM  
Jan-19-21 04:41PM  
Dec-21-20 09:00AM  
Dec-15-20 09:03PM  
Dec-11-20 05:39PM  
05:25PM  
Dec-10-20 10:47PM  
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2020, the company had 103 discovery programs that are either completed, in progress, or under contract. It has a discovery partnership agreement with Eli Lilly and Company. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Falconer EsterChief Technology OfficerMar 19Option Exercise0.031,000,00034,3001,000,000Apr 23 08:00 PM